IL1B and rheumatoid arthritis: This was associated with decreased in vitro osteoclast formation from cell-line macrophages treated both with IL-1β and vitamin D, suggesting that vitamin D may inhibit bone loss in RA patients through blockade of inflammatory cytokine-mediated osteoclast up-regulation [99].